Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 328 entries
View as:

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

Phase: N/A Priority: Normal
NCT ID: NCT00789958 Org: User:
Start: 12/31/08 End: 12/31/17 Due: 12/31/18

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

Phase: N/A Priority: Normal
NCT ID: NCT00873808 Org: User:
Start: 10/31/08 End: 02/28/10 Due: 02/28/11

S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006248 Org: User:
Start: 11/30/00 End: 06/30/05 Due: 06/30/06

Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006484 Org: User:
Start: 11/30/00 End: 04/30/06 Due: 04/30/07

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01097278 Org: User:
Start: 11/01/11 End: 09/30/17 Due: 09/30/18

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01359592 Org: User:
Start: 09/30/11 End: 12/31/23 Due: 12/31/24

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00770120 Org: User:
Start: 12/31/08 End: 04/30/14 Due: 04/30/15

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04871542 Org: User:
Start: 09/13/21 End: 09/30/26 Due: 09/30/27

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Phase: N/A Priority: Normal
NCT ID: NCT02728596 Org: User:
Start: 10/07/16 End: 08/12/21 Due: 08/12/22

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00450281 Org: User:
Start: 10/31/05 End: 07/31/12 Due: 07/31/13

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00134056 Org: User:
Start: 08/31/06 End: 02/29/16 Due: 02/28/17

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00023634 Org: User:
Start: 06/30/01 End: 11/30/08 Due: 11/30/09

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00016393 Org: User:
Start: 06/30/01 End: 04/30/06 Due: 04/30/07

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00937417 Org: User:
Start: 09/30/08 End: 09/30/09 Due: 09/30/10

Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00068289 Org: User:
Start: 09/30/03 End: 07/31/07 Due: 07/31/08

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

Phase: N/A Priority: Normal
NCT ID: NCT00234039 Org: User:
Start: 11/30/06 End: 04/30/13 Due: 04/30/14

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00436332 Org: User:
Start: 07/31/07 End: 08/20/19 Due: 08/20/20

S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00433446 Org: User:
Start: 04/30/07 End: 07/31/11 Due: 07/31/12

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00003828 Org: User:
Start: 05/31/99 End: 03/31/04 Due: 03/31/05

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06773936 Org: User:
Start: 07/15/25 End: 07/31/33 Due: 07/31/34

S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00107276 Org: User:
Start: 08/31/05 End: 08/31/09 Due: 08/31/10

S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002969 Org: User:
Start: 05/31/97 End: 01/31/07 Due: 01/31/08

SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00002548 Org: User:
Start: 01/31/94 End: 11/30/06 Due: 11/30/07

S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00792701 Org: User:
Start: 11/30/08 End: 04/30/16 Due: 04/30/17

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00032084 Org: User:
Start: 01/31/02 End: 02/29/04 Due: 02/28/05